5-(4-Chloro-phenyl)-2-ethynyl-pyridine → 5-(4-Chloro-phenyl)-2-[4-(1-methyl-2-piperidin-1-yl-ethoxy)-phenylethynyl]-pyridine
반응식
I[C:2]1[CH:17]=[CH:16][C:5]([O:6][CH:7]([CH3:15])[CH2:8][N:9]2[CH2:14][CH2:13][CH2:12][CH2:11][CH2:10]2)=[CH:4][CH:3]=1.[Cl:18][C:19]1[CH:24]=[CH:23][C:22]([C:25]2[CH:26]=[CH:27][C:28]([C:31]#[CH:32])=[N:29][CH:30]=2)=[CH:21][CH:20]=1>>[Cl:18][C:19]1[CH:20]=[CH:21][C:22]([C:25]2[CH:26]=[CH:27][C:28]([C:31]#[C:32][C:2]3[CH:17]=[CH:16][C:5]([O:6][CH:7]([CH3:15])[CH2:8][N:9]4[CH2:14][CH2:13][CH2:12][CH2:11][CH2:10]4)=[CH:4][CH:3]=3)=[N:29][CH:30]=2)=[CH:23][CH:24]=1참가 물질
3
실험 절차
Prepared according to general working method I from 1-[2-(4-iodo-phenoxy)-propyl]-piperidine (173 mg, 0.50 mmol) and 5-(4-chloro-phenyl)-2-ethynyl-pyridine (107 mg, 0.50 mmol).
후처리
- customPrepared
출처 및 근거
- ORD 기록
- ord-b8f4291cb56646148372cf886245aec0
- 출처 데이터셋
- uspto-grants-2013_12
- 특허 번호
- US08618132B2
반응 노트
불러오는 중…